Navigation Links
Good Clinical Practice Journal Awards: Winners Announced
Date:9/7/2007

h this made a significant difference to the lives of thousands of renal cancer patients and their families. The main thing for me after working for 11 years in oncology is to have patients ringing up to say thank you."

Another notable winner was South Africa's Aurum Institute for Health Research. It picked up the Most Innovative Patient Recruitment Strategy award for the Thibela TB Study, which used innovative communication techniques to enrol over 38,000 miners to the study. Dr Audrey Banyni, of the Mine Health and Safety Council in South Africa, said: "I am more than happy. In fact, ecstatic. It is a challenging trial because we are involving different mining organisations. The participants are from very different cultural backgrounds, including Zulus and people from Mozambique. We also have the involvement of the labour movement. So it is actually a great achievement for Aurum."

One of the key individual awards of the evening was the Clinical Research Professional of the Year, which was sponsored by the UK Institute of Clinical Research. The winner, Dr Richard Schulz from the CRO Chiltern International in the Czech Republic was praised for being a role model to both CRO and site staff, inspiring them to achieve outstanding result, particularly in an emerging region.

The Clinical Research Team of the Year was sponsored by global CRO i3, and the award was presented to Novartis Pharma's Aclasta/Reclast Horizon RFT Team. Accepting the award on behalf of their colleagues Dr Erik Eriksen and Dr Phil McKernan explained their team "...spread across the Atlantic, half of them were in the US and half were in Basel. So there was a lot time challenges. But the main challenge was that the trial was outsourced to a great extent and to co-ordinate that effort was a testimony to the teams on both sides of the Atlantic. And it has resulted in rapid approval by both the FDA and the CHMP."

The Clinical Research Programme which Best Promoted Access to Medicin
'/>"/>

SOURCE GCPj Awards
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. How do patients benefit of clinical trials
2. Magnetic resonance angiography in clinical medicine
3. Clinical trials need to be more frank
4. AEternas acquisition of Zentaris being followed up with its new product pipeline and clinical development strategy
5. Physicians Lack Clinical Guidelines For Treating Elderly With Multiple Illnesses
6. The Growing Rise In Clinical Research Could Lead To A Compromise In Quality Of Research And Ethics
7. Clinical Comparisons Between ADHD Drugs Are Less
8. Outsourcing clinical trials to India
9. Erectile dysfunction: an early warning sign of clinically silent coronary artery disease?
10. India to maintain Public domain Registry database of clinical trials conducted in India.
11. A Novel System For Clinical Banking Of Umbilical Cord Blood
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2008)..., July 23 /PRNewswire/ -- Philip J. Dwyer, preside...offered testimony before the U.S.,Senate Health, E...tee on,Children and Families today to call for inc...s those implemented at YMCAs across the nation, th...n., Dwyer spoke on behalf of the more than 2,600 ...
(Date:7/23/2008)...vaccines for Immigration and Naturalization ready ..., BALTIMORE, July 23 /PRNewswire/ -- New vaccine ...r an immigrant visa for entry into the U.S. and,an...sidence. Applicants,must show proof of vaccination...nded by the U.S. Advisory Committee on Immunizatio...
(Date:7/23/2008)...DC - July 23, 2008) Biodiversity has long been rec...being. Humans rely on healthy ecosystems to provi...understood is the connection between disease and b...animals found in a geographic region). Recent stu...tect us against diseases such as Lyme disease and ...
(Date:7/23/2008)..., Pa., July 23 /PRNewswire-USNewswire/ -- The Chil...nounce a generous $15 million,gift that will enabl...rristown, Pennsylvania. This gift, made possible b... Pa, is one of the largest in the history of,Child...nd families in the,nearby communities convenient a...
Breaking Medicine News(10 mins):Health News:YMCA Calls on Senate to Fund Community-Based Solutions to Address Childhood Obesity Crisis 2Health News:YMCA Calls on Senate to Fund Community-Based Solutions to Address Childhood Obesity Crisis 3Health News:USCIS Tightens Vaccination Requirements 2Health News:Could preserving biodiversity reduce disease? 2Health News:$15 Million Donation From The Karabots Foundation Enables The Children's Hospital of Philadelphia to Open a New Pediatric Care Facility in Norristown, Pennsylvania 2Health News:$15 Million Donation From The Karabots Foundation Enables The Children's Hospital of Philadelphia to Open a New Pediatric Care Facility in Norristown, Pennsylvania 3
...o protect them against severe strains of the bacte...ontract a serious disease, according to a new stud...ed more than 740 children who lived in 16 diverse ...Results of the study show 28 percent of the childr...
...proved the survival of infants who are born weighi... these babies are at risk for school difficulties ...e prevalence of neurological, behavioral and intel...ren who were born in the early era of neonatal int...
...rts there will be more than 105,000 new cases of c...r diagnosed this year in the United States. When ...of side effects that make quality of life poor. No...l help them live better and with less stress. Clin...
...igation of sociocultural and political change //co... network of social scientists. It includes questio...ey are with their lives. It showed that average ha...in industrialized countries since World War II, al...
Other Medicine News:
(Date:7/23/2008)...23 /- Sound Pharmaceuticals (SPI) has...h the FDA for the clinical,testing of a proprietar...motherapy induced hearing loss or ototoxicity. The...e tested in advanced stage lung cancer,and head an...emotherapy.,This marks the second development prog...
(Date:7/23/2008)...3 /- FluoroPharma Inc., a company dev...the Positron Emission Tomography,(PET) market, ann...el,Fluorine-18 labeled tracer for myocardial perfu...ovascular product to complete Phase I clinical,dev... to assess the blood flow in the,heart (myocardial...
(Date:7/23/2008)... July 23 /- InCode BioPharmaceutics, ... announced preclinical test,results demonstrating ...,the treatment of the rare chronic blood disorder ...plete results will be presented at the XXII,Intern... September 28,2008., The only treatment currentl...
(Date:7/23/2008)...d on IND-Enabling Work with Protein Therapeutics t...lement System, CAMBRIDGE, Mass., July 23 /PRNewsw...it has initiated a corporate growth plan with the,...cutive officer and the,establishment of its headqu...oodruff Emlen, M.D., a co-founder of the company w...
Breaking Medicine Technology:Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer 2FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 2FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 3InCode BioPharmaceutics, Inc. Announces Key Data Supporting New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) 2Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 2Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 3New nanotechnology television series does sweat the small stuff 3839 1New nanotechnology television series does sweat the small stuff 3839 2Jury Awards Mount Vernon Man 2440 1 Million After Medical Device Chars Heart 13974 1Jury Awards Mount Vernon Man 2440 1 Million After Medical Device Chars Heart 13974 2Jury Awards Mount Vernon Man 2440 1 Million After Medical Device Chars Heart 13974 3Jury Awards Mount Vernon Man 2440 1 Million After Medical Device Chars Heart 13974 4Helix BioPharma reports Q2 2008 highlights financial results 3838 1Helix BioPharma reports Q2 2008 highlights financial results 3838 2Helix BioPharma reports Q2 2008 highlights financial results 3838 3Helix BioPharma reports Q2 2008 highlights financial results 3838 4Helix BioPharma reports Q2 2008 highlights financial results 3838 5Helix BioPharma reports Q2 2008 highlights financial results 3838 6Helix BioPharma reports Q2 2008 highlights financial results 3838 7Helix BioPharma reports Q2 2008 highlights financial results 3838 8Helix BioPharma reports Q2 2008 highlights financial results 3838 9Helix BioPharma reports Q2 2008 highlights financial results 3838 10Helix BioPharma reports Q2 2008 highlights financial results 3838 11Helix BioPharma reports Q2 2008 highlights financial results 3838 12Helix BioPharma reports Q2 2008 highlights financial results 3838 13Late treatment with letrozole can reduce breast cancer recurrence risk 13972 1Late treatment with letrozole can reduce breast cancer recurrence risk 13972 2Late treatment with letrozole can reduce breast cancer recurrence risk 13972 3
...SS WIRE)--Jul 11, 2007 - Since the May,2007 releas...rt,that Avandia users are 43 percent more likely t... to die of cardiovascular causes,than non-users of...,to switch many type 2 diabetes patients from Avan...rch from GfK Market Measures,Event Flash, Physici...
...rontera AG (DSE: B8F) announces today,that it has ... part,of its phase IIb/III clinical trial started ...e active substance 5-aminolevulinic acid,(ALA) wit...icantly,superior to placebo in the treatment of ac...c therapy, which eliminates tumor tissue,through a...
Other Medicine Technology:Reaction to Avandia Warnings Stronger Among Internists Than,Endocrinologists, According to Study by GfK Market Measures 2Reaction to Avandia Warnings Stronger Among Internists Than,Endocrinologists, According to Study by GfK Market Measures 3Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy,of BF-200 ALA In Actinic Keratosis 2
...rist orthotic designed to limit the extension of t...g;,35° and 50°). , ,Indications: , Wrist...riangular fibrocartilage complex , Coles fractur...l tendon rupture , ORIF - Open reduction and int...
Contoured design provides secure support and immobilization of the wrist and distal forearm while preserving finger mobility
Bird and Cronin, Inc. is a leading manufacturer of Patient Footwear, Orthopedic Softgoods, and Specialty Patient Care Products. Our products are of the highest quality and available in the USA and In
Bird and Cronin, Inc. is a leading manufacturer of Patient Footwear, Orthopedic Softgoods, and Specialty Patient Care Products. Our products are of the highest quality and available in the USA and In
Medicine Products: